Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited
Company type	Public
Traded as	NSE: EMCURE; BSE: 544210;
ISIN	INE168P01015
Industry	Pharmaceutical
Founded	1981
Founder	Satish Mehta
Headquarters	Hinjawadi, Pune, India
Area served	Worldwide
Key people	Satish Mehta (CEO & MD); Berjis Desai (Chairman); Sunil Mehta (Executive Director); Namita Thapar (Executive Director);
Revenue	₹7,963 crore (US$940 million) (2025)
Operating income	₹981 crore (US$120 million) (2025)
Net income	₹707 crore (US$84 million) (2025)
Number of employees	11,000+ (January 2022)
Website	emcure.com
	Footnotes / references; Financials as of 31 March 2025.

Emcure Pharmaceuticals Limited (Emcure) is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.